Clinical Trials

To view the clinical trials Valley currently has available, please use the search field or select a clinical specialty from the drop-down list below. Be sure to check back frequently, as we are always adding new studies.

For more information about any of our clinical trials, please email clinicaltrialsresearch@valleyhealth.com or call 201-447-8453. (For cancer clinical trials, please call 201-634-5792.)

Learn more about research and clinical trials at Valley.

Clear All

AMAZE

LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT™ SUTURE DELIVERY SYSTEM AS ADJUNCTIVE THERAPY TO PULMONARY VEIN ISOLATION FOR PERSISTENT OR LONGSTANDING PERSISTENT ATRIAL FIBRILLATION

Principal Investigator(s):

  • Dan L. Musat, MD

ARTESiA

Apixaban for the Reduction of Thrombo-Embolism in patients with Device-Detected Sub-Clinical Atrial Fibrillation

Principal Investigator(s):

  • Suneet Mittal, MD

Cardiofit

Impact of a Structured Cardiac Rehabilitation Program on Cardiorespiratory Fitness in Patients with Atrial Fibrillation

Principal Investigator(s):

  • Suneet Mittal, MD

DEFINE AFib

The purpose of this study is to evaluate the association between complex patterns of device-detected AF and other summary and episodic measurements collected by the LINQ ICM device and AF-related healthcare utilization, quality of life, AF-related symptoms, and specific clinical outcomes in patients with a market-released LINQ ICM.

Principal Investigator(s):

  • Suneet Mittal, MD

DRESSLER

Anti-Heart Antibodies Can Predict Early Development of Dressler/s Syndrome After Hybrid Ablation

Principal Investigator(s):

  • Tina C. Sichrovsky, MD

ENVELOPE

A Randomized Noninferiority Study of the TYRX-A Antibacterial Envelope Alone Versus Envelope Plus Intraoperative Antibacterial Irrigant and Postoperative Oral Antibiotics to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Patients

Principal Investigator(s):

  • Suneet Mittal, MD

FROzEN-AF

Safety and Effectiveness IDE Trial for Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation

Principal Investigator(s):

  • Suneet Mittal, MD

MARVEN

Clinical, Electrocardiographic, and Cardiac Magnetic Resonance Imaging Risk Factors Associated with Ventricular Tachyarrhythmias in Nonischemic Cardiomyopathy (MARVEN Study)

Principal Investigator(s):

  • Dan L. Musat, MD

OPTIMIZER SMART (PAS)

A Prospective, Multi-center, Non-randomized, Single Arm Open Label Study of 620 Subjects Receiving the OPTIMIZER Smart With CCM Therapy as Standard of Care

Principal Investigator(s):

  • Suneet Mittal, MD

OPTION

Comparison of Anticoagulation with Left Atrial Appendage Closure after AF Ablation (OPTION)

Principal Investigator(s):

  • Suneet Mittal, MD